Patent · US Active

Cell

US10174099B2 · kind B2 · utility

4Cited by
2References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 23, 2017
Grant dateJan 8, 2019
Priority date
Expiry dateJun 23, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a cell which co-expresses a first chimeric antigen receptor (CAR) and second CAR at the cell surface, each CAR comprising an antigen-binding domain, wherein the antigen-binding domain of the first CAR binds to CD19 and the antigen-binding domain of the second CAR binds to CD22.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.